Respiratory
Boehringer Ingelheim has over 90 years of heritage in managing respiratory disease. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life
Regional ILD Masterclass Ep.2: Why even wait until there is 10% relative FVC decline? – Dr. Felix Chua
30/04/2024 | Author: Boehringer Ingelheim
Document ID: PC-TH-104744
RELATED CONTENT
3:45